Mayo Clinic is one of the few medical centers in the U.S. recognized as a Specialized Program of Research Excellence (SPORE) for pancreatic cancer research, funded by the National Cancer Institute (NCI). In the Mayo Clinic Gastrointestinal Cancer Program, new diagnostic tools, treatments and approaches to prevention of pancreatic cancer are being studied.
Mayo Clinic is also actively involved in a large NCI-funded multisite study, conducted by the Pancreatic Cancer Genetic Epidemiology (PACGENE) Consortium, looking at the role heredity plays in the disease. To aid this research, Mayo Clinic has created an extensive patient and tissue registry for pancreatic cancer.
See a list of publications by Mayo Clinic doctors on pancreatic cancer on PubMed, a service of the National Library of Medicine.